LUNG

Pulmonx Corp

Latest Form 4:Sale$22KbyRadhakrishnan Srikanth (Chief Science &Techn. Officer) · filed Jun 3, 2026

Pulmonx Corp (LUNG) has 23 SEC Form 4 filings (64 transaction rows) in the rolling window, disclosed by 7 distinct insiders. Most recent filing: Jun 9, 2026.

The most active filer is CHIEF COMMERCIAL OFFICER Rose Geoffrey Beran with 4 filings. Insiders have net sold $285K over the trailing 6 months.

  • Industry:Medical - Devices
  • CEO:Glendon E. French
  • Employees:296
  • HQ:Redwood City, CA, US
  • IPO:2020-10-01

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$425K

reported sales (SEC code S)

Unique Insiders

7

in the rolling window

Market Cap

$102.2M

latest known value

Source
Radhakrishnan SrikanthFirst in 3 months
Sale$22KJun 3SEC ↗
Rose Geoffrey BeranFirst in 3 months
Sale$12KJun 3SEC ↗
Lehman David AaronFirst in 3 months
Sale$22KJun 3SEC ↗
French Glendon E. IIIFirst in 3 months
Sale$66KJun 3SEC ↗
French Glendon E. IIIFirst in 3 months
Sale$21KJun 3SEC ↗
Rose Geoffrey BeranFirst in 3 months
Sale$11KMar 4SEC ↗
Sale$15KMar 4SEC ↗
Lehman David AaronFirst in 3 months
Sale$17KMar 4SEC ↗
French Glendon E. IIIFirst in 3 months
Sale$97KMar 4SEC ↗
Florin Daniel PFirst filing
Sale$46KDec 9SEC ↗
Lehman David AaronFirst in 3 months
Sale$16KDec 3SEC ↗
Rose Geoffrey BeranFirst in 3 months
Sale$10KDec 3SEC ↗
Sale$14KDec 3SEC ↗
Lehman David AaronFirst filing
Sale$16KSep 3SEC ↗
Sale$10KSep 3SEC ↗
Sale$15KSep 3SEC ↗
Joshi MehulFirst filing
Sale$13KSep 3SEC ↗

Related companies

Pulmonx Corp is in the Healthcare sector.